A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis Interventions: Drug: TQA3526; Drug: Placebo to match TQA3526 Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials